Alternatives to Medsol RX

A fast, fully async start with a needle-free sublingual tirzepatide option and — a genuine upgrade since our last check — flat pricing stated in writing. The catch is a state list it still won't publish.

The one brand in this cluster that prints its prices: seven weight-loss products, compounded and brand, each with a public number. What it will not tell you is when anything arrives, or how you would ever stop.

Pallas Health removes the two things that usually cost a working parent the most time: it publishes every price before intake, and it runs care asynchronously in 43 of 50 states, so there's no video appointment to wedge into a workday. Compounded semaglutide averages about $199 a month and tirzepatide $299, and unusually the genuine FDA-approved pens sit alongside them — Zepbound $1,069, Ozempic $1,299, Wegovy and Mounjaro $1,349 — all cash-pay from the same clinician. The price is flat at every dose, so a titration never produces a surprise bill, and the plan figure already contains the clinician, dose adjustments, check-ins and messaging with no membership fee. Its cancellation terms are unusually concrete: cancel free through the portal, keep access to the end of the paid period, full refund if a clinician declines you, and a $5 processing fee on a qualifying refund. The trade-offs are that billing lands every 12 weeks in $597 and $897 blocks rather than monthly, the compounding pharmacy is never named, and insurance is never billed.

One flat $195/mo plan covers compounded semaglutide, compounded tirzepatide, or a needle-free sublingual option — plus real brand-name access if you want an FDA-approved pen instead — with a women's-health-first framing and a $99 first month, though it won't name your state until you're inside the signup flow.

Compounded semaglutide at $199 a month and tirzepatide at $299, the same price at every dose, and the daily tablet costs the same as the injection on both — all of it on an open pricing page you reach without a quiz. Brand-name prices are published too, which is rare: Wegovy $999, Ozempic $899, Mounjaro $999, cash. Two things to know before you enter a card. The badge at the top of every page says no subscription, and its own FAQ then asks whether you can cancel your subscription and tells you to call before your next billing date — so it does recur, whatever the badge says. And nothing anywhere on the site says how many weeks of medication one $199 charge actually buys. It ships to all 50 states, and it carries a June 2026 FDA warning letter for false or misleading claims, which it has since fixed.

The widest menu on the board — compounded, oral and four brand pens, all on a chat visit with no camera — sold behind a pricing page that quotes you a monthly figure for a plan you have to pay for a year in advance.

Pepti publishes the lowest semaglutide price in this entire roster — $99 a month, flat at every titration dose, with the medication, physician review, shipping, refill management and unlimited messaging with your prescribing doctor all inside it. Tirzepatide is $199 on the same all-in, flat-at-every-dose basis. That number is low enough to deserve skepticism, so it is worth saying exactly where it comes from: Pepti states it on a dedicated cost page, repeats it in its FAQ ('we keep pricing flat and transparent at $99/mo all-in'), and prices the comparison against Hims, Henry Meds and Mochi on the same page. It names two prescribing physicians and says its medication is compounded by FDA-registered 503A or 503B pharmacies, though it never names which. The real limits are reach and format: it ships to 36 states rather than 50, it is cash-pay only and bills no insurance, and its needle-free oral GLP-1/GIP drops cost $349 — well above its own injection.

A rare compounded-plus-brand shop with five real price points disclosed up front — $179/mo compounded semaglutide up to $1,086/mo brand Zepbound — though the oral tablet's exact molecule split isn't fully clear.

The complete ladder is on the page before any intake, which almost nothing else here does: semaglutide $199 a month, $549 for three months, $999 for six, $1,788 for twelve; tirzepatide $299, $797, $1,494, $2,748. Read the long tiers correctly — each is a single upfront charge rather than a smaller monthly bill, so the advertised $149 means paying a full year before the first box ships. Disclosure is above average where it counts. Andrew Meds LLC is named with a Houston address, and the practice that writes the prescription is named separately as Dr Tel X in Kennewick, Washington. Coverage is all fifty states and DC, enumerated rather than claimed, and there is an oral tirzepatide alongside the injections. The gaps: the compounding pharmacy is never named, no time to first dose is published, and a period you have partly used is not refunded.